Literature DB >> 29194671

Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine.

Khaled Alnuaimi1, Julie Lavolé1, Caroline Lascoux-Combes2, Anne-Marie Roque Afonso3,4,5, Philippe Sogni1,6,7, Stanislas Pol1,6,7, Vincent Mallet1,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29194671     DOI： 10.1002/hep.29697

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  1 in total

1.  Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E.

Authors:  Marten Schulz; Paula Biedermann; Claus-Thomas Bock; Jörg Hofmann; Mira Choi; Frank Tacke; Leif Gunnar Hanitsch; Tobias Mueller
Journal:  Int J Environ Res Public Health       Date:  2020-01-03       Impact factor: 3.390
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.